Toyobo (TSE:3101) Stock Rethinks Its Discount After Profits Nearly Doubled

Simply Wall St · 1d ago

Toyobo stock came into this earnings print priced for doubt, with a flat week, a weak month and a trailing P/E of 11.3x that sits below both peers and the wider Japan chemicals sector. The results forced a sentiment check. Net income from continuing operations over the trailing year is ¥16,353m with a 3% net margin that now stands clearly above last year’s 0.7%. The market is reacting to a story that once looked like a long slide in profits, yet now shows a sharp earnings rebound that clashes with the cautious valuation visible on screen.

Impressed by Toyobo's earnings rebound but cautious about a stock that still carries a discount label? Explore a wider field of companies screened for resilient balance sheets and fundamentals in our list of solid balance sheet and fundamentals stocks (40 results).

Q1 2027 Earnings Summary

  • Revenue (Q1 2027 vs Q1 2026): ¥110,373m vs. ¥102,910m (up 7.3%)
  • Net Income from Continuing Operations (Q1 2027 vs Q1 2026): ¥3,072m vs. ¥1,573m (up 95.3%)
  • Basic EPS (Q1 2027 vs Q1 2026): ¥34.81 per share vs. ¥17.84 per share (up 95.1%)
  • Trailing 12 Month Net Profit Margin (Q1 2027 vs Q1 2026): 3.0% vs. 0.7% (margin is now more than four times higher year on year)

Prefer clear charts over scanning line after line of earnings figures and ratios? See Toyobo's full valuation picture in a visual format, including how the current P/E and profit margin fit into the story in our company report for Toyobo.

TSE:3101 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
TSE:3101 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Toyobo bull case, recovery milestones under review

Bulls argue Toyobo is in a clear earnings and cash flow recovery led by Industrial Films and cleaner execution in turnaround businesses. The latest Q1 numbers support that story at the income statement level. Revenue reached ¥110,373m and net income from continuing operations was ¥3,072m. Basic EPS was ¥34.81 and the trailing net margin is 3.0%, compared with 0.7% a year earlier. That points to better pricing, mix or cost control, which fits with progress in Airbag Fabrics and Nonwoven materials. The strong Q1 profit growth also aligns with earlier upgrades to full year profit guidance and the claim that cash generation has improved after capex discipline. For now, the recovery narrative looks on track, with the main milestones of higher profitability and more efficient use of capital showing up in reported earnings.

Bear case, structural risks and execution still in play

Bears focus on execution risk in slower areas such as life sciences, exposure to oil related cost swings and the possibility that accounting items like higher depreciation could cap earnings even when cash flow is healthier. The Q1 figures do not settle those concerns. The margin improvement to 3.0% sits on a relatively low base and remains modest for a chemicals group, so any input cost shock could pressure it. The narrative also flags delayed recovery in biotech and risks around plant consolidations, and Q1 does not yet provide clear proof that these are fully behind Toyobo. Recent share performance backs the idea that investors are still cautious, with the stock down about 8.7% over 30 days, roughly flat over 7 days and positive over 90 days.

Compare Toyobo's earnings rebound story with what the street is actually pricing in. See the consensus price target analysis for Toyobo to check whether analyst targets are keeping pace with the latest profitability and margin data.

Stay Ahead With Simply Wall St

If Toyobo's earnings rebound and current P/E of 11.3x have caught your attention, register for free with Simply Wall St and add it to a Watchlist to keep an eye on price versus fair value and watch for an entry point that fits your plan. After you take a position, stay focused on what matters by using the Portfolio Command Center which highlights key events and fundamental changes instead of day to day noise. For a longer term perspective, compare your view with thousands of investors through the Community and see how sentiment evolves as new data comes in. This way you can monitor potential catalysts or emerging risks early and stay a step ahead of the wider market.

Seeking Alternatives Beyond Toyobo Now

Markets move fast and the next breakout stories rarely stay under the radar for long. Scan these fresh ideas before the momentum is fully caught and act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.